Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
48.1M
-
Shares change
-
+4.27M
-
Total reported value, excl. options
-
$2.68B
-
Value change
-
+$241M
-
Put/Call ratio
-
0.16
-
Number of buys
-
119
-
Number of sells
-
-78
-
Price
-
$55.51
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q2 2021
231 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q2 2021.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.1M shares
of 69.1M outstanding shares and own 69.68% of the company stock.
Largest 10 shareholders include FMR LLC (6.63M shares), BlackRock Inc. (4.52M shares), VANGUARD GROUP INC (3.5M shares), Capital Research Global Investors (3.09M shares), WELLINGTON MANAGEMENT GROUP LLP (2.6M shares), ALLIANCEBERNSTEIN L.P. (2.12M shares), Clearbridge Investments, LLC (1.93M shares), JANUS HENDERSON GROUP PLC (1.4M shares), RIVERBRIDGE PARTNERS LLC (1.08M shares), and AMERICAN CENTURY COMPANIES INC (1.07M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.